Friday, 16 September 2016

EpiPen Maker Lobbies to Shift High Costs to Others

Inclusion on a federal list would mean Mylan could keep its list price high - or even raise it - without patients' complaining. But consumers would feel it indirectly.

No comments:

Post a Comment